Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial

Autor: Matasar, Matthew, Bartlett, Nancy L., Shadman, Mazyar, Budde, Lihua E., Flinn, Ian, Gregory, Gareth P., Kim, Won Seog, Hess, Georg, El-Sharkawi, Dima, Diefenbach, Catherine S., Huang, Huang, To, Iris, Parreira, Joana, Wu, Mei, Kwan, Antonia, Assouline, Sarit
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia April 2024 24(4):240-253
Databáze: ScienceDirect
Externí odkaz: